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RESEARCH
Internet based vestibular rehabilitation with and without  
physiotherapy support for adults aged 50 and older with a 
chronic vestibular syndrome in general practice: three armed 
randomised controlled trial
Vincent A van Vugt,1 Johannes C van der Wouden,1 Rosie Essery,2 Lucy Yardley,2 Jos W R Twisk,3 
Henriëtte E van der Horst,1 Otto R Maarsingh1
ABSTRACT
OBJECTIVE
To investigate the clinical effectiveness and safety of 
stand alone and blended internet based vestibular 
rehabilitation (VR) in the management of chronic 
vestibular syndromes in general practice.
DESIGN
Pragmatic, three armed, parallel group, individually 
randomised controlled trial.
SETTING
59 general practices in the Netherlands.
PARTICIPANTS
322 adults aged 50 and older with a chronic vestibular 
syndrome.
INTERVENTIONS
Stand alone VR comprising a six week, internet based 
intervention with weekly online sessions and daily 
exercises (10-20 minutes a day). In the blended VR 
group, the same internet based intervention was 
supplemented by face-to-face physiotherapy support 
(home visits in weeks 1 and 3). Participants in the 
usual care group received standard care from a 
general practitioner, without any restrictions.
MAIN OUTCOME MEASURES
The primary outcome was vestibular symptoms after 
six months as measured by the vertigo symptom 
scale-short form (VSS-SF range 0-60, clinically relevant 
difference ≥3 points). Secondary outcomes were 
dizziness related impairment, anxiety, depressive 
symptoms, subjective improvement of vestibular 
symptoms after three and six months, and adverse 
events.
RESULTS
In the intention-to-treat analysis, participants in the 
stand alone and blended VR groups had lower VSS-SF 
scores at six months than participants in the usual 
care group (adjusted mean difference −4.1 points, 
95% confidence interval −5.8 to −2.5; and −3.5 
points, −5.1 to −1.9, respectively). Similar differences 
in VSS-SF scores were seen at three months follow-up. 
Participants in the stand alone and blended VR groups 
also experienced less dizziness related impairment, 
less anxiety, and more subjective improvement of 
vestibular symptoms at three and six months. No 
serious adverse events related to online VR occurred 
during the trial.
CONCLUSION
Stand alone and blended internet based VR are 
clinically effective and safe interventions to treat 
adults aged 50 and older with a chronic vestibular 
syndrome. Online VR is an easily accessible form of 
treatment, with the potential to improve care for an 
undertreated group of patients in general practice.
TRIAL REGISTRATION
Netherlands Trial Register NTR5712.
Introduction
Vestibular symptoms such as vertigo and dizziness 
are common in general practice.1 Each year 5% of the 
general population experiences vertigo symptoms.2 
The prevalence, frequency, and severity of vertigo 
generally increases with age.2 3 Four out of five people 
with vertigo report that it severely affects their daily 
functioning.4 Vertigo also represents a substantial 
economic burden, as a result of absenteeism, high 
use of healthcare services, and an increased risk of 
falling.2  5 More than 80% of patients experiencing 
vertigo in the Netherlands, United Kingdom, and 
United States are primarily treated by their general 
practitioner or primary care doctor and are never 
referred to a medical specialist for their symptoms.6-8
In the International Classification of Vestibular 
Disorders, developed by the leading international 
Bárány society for neuro-otology, four types of 
vestibular symptoms are identified: vertigo, dizzi-
ness, vestibulovisual symptoms, and postural symp-
toms.9 10 No vestibular symptom is considered 
pathognomonic in its links to underlying vestibular 
disease, and the same patient often experiences 
more than one vestibular symptom.10 11 Peripheral 
vestibular dysfunction due to disorders such as benign 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
In chronic vestibular syndromes, patients experience vestibular symptoms 
(vertigo, dizziness, vestibulovisual symptoms, postural symptoms) with features 
suggestive of persistent vestibular system dysfunction for months to years
Vestibular rehabilitation (VR) is a form of exercise therapy designed to optimise 
the process of vestibular compensation, which is disrupted in patients with a 
chronic vestibular syndrome
Although considered the preferred treatment for chronic vestibular syndromes, 
VR is still largely underused in general practice
WHAT THIS STUDY ADDS
In adults aged 50 and older with a chronic vestibular syndrome in general 
practice, internet based VR, both with and without physiotherapy support, 
resulted in a clinically relevant decrease in vestibular symptoms compared with 
usual care at six months
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paroxysmal positional vertigo, vestibular neuritis, 
vestibular migraine, or Meniere’s disease is the most 
important cause of vestibular symptoms.2 Each 
peripheral vestibular disorder has a distinct initial 
treatment, and they all have a substantial potential 
to result in chronic vestibular symptoms.12 When a 
vestibular disorder damages the peripheral vestibular 
system, an innate repair mechanism called vestibular 
compensation is activated that aids functional recovery 
and decreases vestibular symptoms.13 When vestibular 
compensation fails, a chronic vestibular syndrome 
can occur.12 This is defined in the International 
Classification of Vestibular Disorders as a clinical 
syndrome of chronic vestibular symptoms, lasting 
months to years, which includes features suggestive 
of persistent vestibular system dysfunction. Symptoms 
in chronic vestibular syndromes can either have a 
progressively deteriorating course, reflect a stable, yet 
incomplete recovery after an acute vestibular event, 
or represent persistent, lingering symptoms between 
episodic vestibular attacks.10 11
Vestibular rehabilitation (VR), an exercise based 
treatment that gradually stimulates the vestibular 
system, can be used to stimulate vestibular com-
pensation.12 Moderate to strong evidence shows that VR 
is a safe and effective treatment for unilateral peripheral 
vestibular dysfunction.14 VR is now recommended in 
US,15 16 UK,17 and Dutch18 clinical guidelines as the 
preferred treatment for a chronic vestibular syndrome. 
Despite the scientific evidence for VR, less than 10% 
of general practitioners in the Netherlands19 and 
UK20 reported its use. Investigating alternative ways 
to deliver VR in general practice may stimulate the 
implementation of VR. Internet interventions are 
easily accessible and inexpensive and can be tailored 
to the patient’s needs. The University of Southampton 
used the content of an effective VR booklet21 22 to 
develop an online VR intervention.23 In a randomised 
controlled trial in the UK this fully automated stand 
alone internet based intervention effectively reduced 
vestibular symptoms compared with usual care.24 
Stand alone internet based interventions are prone 
to non-adherence and attrition, and therefore online 
treatment is often combined with face-to-face therapy 
by a healthcare professional.25-27 Thus, combining 
online VR with physiotherapy support might provide 
even better results. This guided approach with 
physiotherapy support, known as blended care, 
might be especially effective in people with vestibular 
symptoms, as anxiety is strongly associated with 
vestibular disorders.28-31 Physiotherapists are used to 
reassure and encourage participants doing vestibular 
exercises and regard the management of anxiety as 
an important aspect of treatment.16 32 We investigated 
the clinical effectiveness and safety of stand alone and 
blended internet based VR versus usual care for adults 
aged 50 and older with a chronic vestibular syndrome 
in primary care. We hypothesised that both stand 
alone and blended internet based VR would result in 
a clinically relevant decrease in vestibular symptoms 
compared with usual care after six months.
Methods
We conducted a pragmatic, three group, parallel arm, 
individually randomised controlled trial among adults 
aged 50 and older with a chronic vestibular syndrome. 
The clinical effectiveness and safety of stand alone 
and blended internet based VR with physiotherapy 
support was compared with usual care. A detailed 
study protocol has been published,33 and the trial 
was registered in the Netherlands Trial Register 
before the first patient was recruited. We followed the 
CONSORT reporting guidelines for non-drug treatment 
interventions.34
Participants
We recruited participants from 59 general practices 
in the Netherlands. A search of the electronic medical 
records identified eligible adults aged 50 and older 
who had visited their general practitioner with a 
vestibular symptom in the past two years. The doctor 
screened the list of potentially eligible participants 
and excluded those with an identifiable non-vestibular 
cause of their symptoms, medical contraindications 
for making the required head movements (eg, severe 
cervical arthrosis), serious comorbid conditions 
precluding participation in an exercise programme, or 
current enrolment in another similar study. Potential 
participants received information about the trial and a 
form to express interest. One of the physicians in the 
research team (VAvV or ORM) checked the eligibility 
criteria of interested patients by telephone. The 
inclusion criteria were a good command of the Dutch 
©  BMJ Publishing group Ltd.http://bit.ly/BMJintvr
Outcomes
Comparison
Study design
Internet based vestibular rehabilitation is a safe and effective 
treatment, with the potential to improve care for an undertreated 
group of patients in general practice
Summary
Population 322
participants
% women
Mean age 
Patients with a chronic 
vestibular syndrome aged ≥
Visual Abstract Internet based vestibular rehabilitation
With and without physiotherapy support
Randomised controlled trial Patients in Dutch general practices
Trial registration: NTR
Baseline score (mean)
Score at  months (mean)
14.1
8.1
7.5
13.8
8.6
8.7Score at  months (mean)
Stand alone
rehabilitation
Usual care Blended
rehabilitation
Primary outcome
Vertigo symptom scale 
– short form (VSS-SF)
Significance
Clinical significance defined 
as a change of ≥3 points
Scale
-, a score of  or more points
indicates severe vestibular symptoms
13.2
11.5
10.9
Adjusted mean
difference  % CI
-5.5 to -2.3-3.9
-5.1 to -1.9-3.5
Adjusted mean
difference  % CI
-5.9 to -2.6-4.3
-5.8 to -2.5-4.1
Usual GP care
Without any restrictions
Online sessions 
Weekly for six weeks 
Physiotherapy
Face-to-face
12098 104
+ + +
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language, access to the internet and an email account, 
and persisting vestibular symptoms at time of inclusion 
that had been present for at least one month and were 
exacerbated or triggered by head movements. These 
inclusion criteria allowed us to identify participants 
with a chronic vestibular syndrome, as defined in the 
International Classification of Vestibular Disorders10 11 
who were suitable to receive online vestibular rehabili-
tation. The research team physician used a checklist 
(supplementary appendix 1) to distinguish a chronic 
vestibular syndrome from an acute or episodic 
vestibular syndrome.10 11
Interventions
Stand alone internet based VR
VR entails specific exercises for maximising central 
nervous system compensation for vestibular disease. 
Additionally, provoking vestibular symptoms in a 
controlled context constitutes a form of exposure 
based behaviour therapy.35 36 Booklet based VR is an 
effective method for reducing vestibular symptoms 
and dizziness related impairment.21 22  37 These 
booklets served as the basis for a British online 
intervention, called Balance Retraining (freely availa-
ble from https://balance.lifeguidehealth.org/).23 24  35 
The development of Balance Retraining employed 
a person based approach, drawing on an in-depth 
understanding of intervention target users.38 39 It 
was built using LifeGuide software (University of 
Southampton, Southampton, UK). Vertigo Training, 
the internet based VR intervention we used in this trial, 
was a Dutch translation of Balance Retraining.
The intervention period lasted six weeks. Vertigo 
Training consisted of weekly online sessions and 
daily VR exercises (supplementary appendix 2). 
In the first session, written instructions and video 
demonstrations were used to teach participants the six 
core VR exercises. Participants were asked to perform 
these exercises twice daily for 10 minutes during the 
intervention period. Exercises were tailored to the 
individual by taking into account the participants’ 
symptoms and balance capabilities. At the start of 
the intervention, participants performed all exercises 
sitting down and directly afterwards scored the level 
of vestibular symptoms associated with each of the 
six exercises. Vertigo Training scores were used to 
automatically produce an exercise prescription for 
the coming week, custom-built to the participant’s 
vestibular symptoms. Every week participants scored 
the vestibular symptoms associated with each of the 
six exercises in a new online session. When an exercise 
was performed while sitting down and no vestibular 
symptoms were elicited (anymore), the difficulty 
level was increased by an instruction to perform that 
specific exercise while standing or eventually when 
walking around. Through this personalised approach, 
participants gradually increased the intensity of their 
exercises and continued to challenge their vestibular 
system. Vertigo Training also provided information 
and advice on coping and symptom control strategies 
(supplementary appendix 2).37 Muscle relaxation and 
breathing techniques can decrease psychophysiological 
arousal, whereas cognitive restructuring and problem 
solving might lessen anxiety provoked by vestibular 
symptoms.40 In addition, Vertigo Training included 
several features to increase engagement. To raise 
participants’ expectations about the content of Vertigo 
Training, scientific studies supporting the effectiveness 
of VR were summarised in plain language. Participants 
received email messages to remind them to log in to 
the website each week. Participants also received the 
standard level of care provided by their own doctor, 
without restrictions.
Blended internet based VR with physiotherapy 
support
Participants in the blended VR group received access to 
the same Vertigo Training intervention as participants 
in the stand alone VR group. In addition, a trained 
physiotherapist visited participants in the blended VR 
group twice at home. These physiotherapy sessions 
occurred in weeks 1 and 3 of the six week intervention 
period and lasted for 45 minutes each. During these 
sessions, the physiotherapist: provided information 
about the background of vestibular symptoms and 
VR, elicited and addressed doubts and concerns about 
vestibular symptoms and VR, taught participants how 
to use the online intervention, described and took 
participants through a set of VR exercises, advised 
on how to anticipate and cope with obstacles to 
adherence, and provided support and encouraged 
adherence. The first session was designed to make 
the participant feel comfortable with the VR exercises, 
and the second session focused on adherence to 
treatment. Participants in this group also received the 
standard level of care provided by their doctor, without 
restrictions.
Usual care
Participants in the usual care group received the 
standard level of care provided by their doctor, 
without restrictions. They had access to any treatment 
available in primary care or in secondary care after 
referral. Participants in the usual care group were 
offered access to stand alone internet based VR after 
the trial was completed. Participating doctors received 
written instructions, asking them to diagnose causes 
of vestibular symptoms and treat identified disorders 
for all participants according to the guidelines of the 
Dutch College of General Practitioners.18
Outcomes
Measurements were collected at baseline and at three 
and six months follow-up. The primary outcome 
measure was vestibular symptoms as measured by 
the vertigo symptom scale-short form (VSS-SF)41 42 
six months after baseline. The VSS-SF has been used 
effectively in several VR trials21 22 24 37 and has shown 
excellent discriminative ability (area under the curve 
0.87), high internal consistency (Cronbach’s α 0.90), 
and high test-retest reliability (intraclass correlation 
coefficient 0.88).42 The instrument measures the 
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frequency of 15 vestibular symptoms on a scale from 0 
(no symptoms) to 4 (symptoms most days) during the 
past month (total range 0-60 points). Improvement can 
reflect either fewer or less frequent symptoms. A total 
score of 12 points or more has been classified as severe 
vestibular symptoms,22 and a change in score of 3 
points or more has been defined as clinically signifi-
cant.21 22 24 37 A clinically relevant improvement on the 
VSS-SF can represent either marked improvement on 
one symptom (eg, vertigo) or some improvement on 
three symptoms (eg, vertigo, nausea, and unsteadiness). 
Secondary outcome measures included the dizziness 
handicap inventory,43 which measures dizziness related 
impairment; subjective improvement in vestibular 
symptoms,37 a single dichotomous item that indicated 
whether participants felt they had or had not improved 
(ie, worse or the same) compared with baseline; and 
the patient health questionnaire (PHQ)44 to determine 
the presence of a panic disorder, generalised anxiety 
disorder, or major depressive disorder, and to measure 
the severity of anxiety (generalised anxiety disorder 
assessment (GAD)-7 subscale)45 and depressive symp-
toms (PHQ-9 subscale).46 In participants in the stand 
alone and blended VR groups, we also assessed self 
reported perceived barriers to adherence with the 
problematic experiences of therapy scale (PETS).47 At 
baseline, we asked participants to report demographic 
characteristics (age, sex, level of education, and living 
situation), comorbidities, the vestibular diagnosis, 
frequency and average duration of vestibular 
symptoms, and time since vestibular diagnosis. 
Engagement in Vertigo Training was measured by 
automatically collected data for intervention usage, 
number of sessions completed, and time spent on each 
page of the trial website. We reported all serious adverse 
events that occurred during the trial to the medical 
ethics committee. The relation of all serious adverse 
events with vestibular symptoms or the intervention 
was judged, after contacting the participant or general 
practitioner, or both.
Randomisation and blinding
Participants who completed the informed consent 
procedure received an email with a link to the trial 
website. After participants had filled out the baseline 
questionnaire, the LifeGuide software allocated them 
to stand alone VR, blended VR, or usual care. A simple 
randomisation algorithm stratified participants by 
severity of vestibular symptoms using a cut-off of 12 
or higher on the VSS-SF. The automated randomisation 
process took place online and was concealed from 
the research team. Owing to the nature of the trial 
interventions, it was not possible to blind participants, 
physiotherapists, and research assistants. The trial 
statistician (JWRT) remained blinded to allocation 
until the analyses had been completed.
Sample size
Our sample size calculation was based on the 
comparison between participants allocated to stand 
alone VR and those allocated to usual care. We chose 
this comparison because, based on previous blended 
internet based research projects,25-27 we anticipated 
that blended VR would be just as effective or more 
effective than stand alone VR. In a previous VR trial 
with VSS-SF as the primary outcome measure, booklet 
based VR alone compared with usual care showed an 
effect size (Cohen’s d) of 0.45, favouring booklet based 
VR.21 To be able to detect such an effect, and assuming 
that stand alone internet based VR would produce 
the same effect size as booklet based VR, we needed 
80 participants in each group for a two sided test with 
an α of 0.05 and β of 0.20. As attrition from internet 
based interventions can be substantial,25 we recruited 
a minimum of 100 participants in each group (300 
total sample) to allow for up to 20% loss to follow-up.
Statistical analyses
We used descriptive statistics to compare the baseline 
characteristics of participants in the three trial arms. 
For the primary intention-to-treat analysis, participants 
were analysed according to their randomisation group. 
The two comparisons were stand alone internet 
based VR versus usual care and blended internet 
based VR with physiotherapy support versus usual 
care. In a secondary per protocol analysis we only 
included participants assigned to stand alone VR who 
completed all six online sessions, and we only included 
participants assigned to blended VR who completed all 
six online sessions and both physiotherapist visits. We 
used a linear mixed models analysis for continuous 
outcome variables, and generalised estimating equa-
tion analysis for binary outcome variables. These 
techniques can account for repeated measures within 
an individual and are also capable of handling 
missing data in a longitudinal dataset without the 
need to perform multiple imputations.48 For each 
outcome measure we reported a crude and an adjusted 
analysis. The crude analysis included the group 
variable (using the usual care group as reference), 
time, and the interaction between the group variable 
and time. Furthermore, we adjusted for the baseline 
values of the outcome, as is customary in randomised 
controlled trials,49 and for other prespecified potential 
confounders—that is, age (continuous),50-54 sex 
(categorical),50 55 level of education (categorical),54 
living situation (categorical),54 56 number of chronic 
diseases (categorical),50 54 56 57 time since diagnosis 
(categorical),55 56 58 and the presence of a panic 
disorder, generalised anxiety disorder, or major 
depressive disorder at baseline (categorical).50 56 57-59 
Lastly, we conducted a post hoc analysis to assess 
possible effect modification in the primary intention-
to-treat analysis for each potential confounder by 
using interaction terms in the model. SPSS 22.0 and 
Stata 14.1 were used for statistical analyses.
Patient and public involvement
Patients played an important role in the development 
of Vertigo Training. Detailed feedback by patients with 
vestibular symptoms on the content, usability, and 
Dutch translation in prototype versions led to some 
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amendments of the online intervention. No patients 
advised on interpretation of the results nor were they 
involved in writing the manuscript. A lay summary 
of the research findings will be distributed to all 
participants and the results will be disseminated to the 
relevant patient community.
Results
Participants were recruited between June 2017 and 
July 2018 from 59 Dutch general practices. Figure 1 
shows the patient flow during the trial. At baseline, 
322 participants were randomised: 98 to the stand 
alone VR group, 104 to the blended VR group, and 
120 to the usual care group. Follow-up data on the 
primary outcome was complete at three and six 
months for 292 (91%) and 286 (89%) of participants, 
respectively. Table 1 shows the baseline characteristics 
of participants. The groups were generally well 
balanced, although the usual care group comprised 
relatively more men. In the stand alone VR group, 
70 participants (71%) completed at least one online 
session and 47 (48%) completed all six sessions. In the 
blended VR group, 83 participants (80%) completed 
at least one online session, 85 (82%) received both 
physiotherapist visits, and 55 (53%) completed all six 
sessions and were visited twice by the physiotherapist.
Primary outcome
In the intention-to-treat analysis, participants at 
three and six months follow-up in both the stand 
alone VR group and the blended VR group reported 
fewer vestibular symptoms than participants in 
the usual care group  (table 2). After controlling 
for baseline values and prespecified confounders, 
participants in the stand alone VR group scored 4.3 
points lower on the VSS-SF than participants in the 
usual care group at three months (95% confidence 
interval −5.9 to −2.6) and 4.1 points lower at six 
months (−5.8 to −2.5). Participants in the blended 
VR group scored 3.9 points lower than participants 
in the usual care group at three months (−5.5 to −2.3) 
and 3.5 points lower at six months (−5.1 to −1.9). 
The differences between groups were statistically 
significant and exceeded the clinically relevant 
difference of 3 points. In the per protocol analysis, 
participants in the stand alone VR group reported a 
5.4 point lower VSS-SF score at six months compared 
with participants in the usual care group (95% 
confidence interval −7.4 to −3.4), and the blended 
VR group scored 3.5 points lower than the usual care 
group (−5.5 to −1.6). In a post hoc analysis, no effect 
modification was found for the primary outcome 
(supplementary appendix 3).
Table 1 | Baseline characteristics of participants assigned to stand alone vestibular rehabilitation (VR), blended VR, or 
usual care. Values are numbers (percentages) unless stated otherwise
Characteristics Stand alone VR (n=98) Blended VR (n=104) Usual care (n=120) Total sample (n=322)
Mean (SD) age (years) 66.7 (9.5) 67.4 (9.8) 67.0 (9.4) 67.0 (9.5)
Female 64 (65) 69 (66) 64 (53) 197 (61)
Level of education:        
 Low 33 (34) 37 (36) 36 (30) 106 (33)
 Middle 25 (26) 31 (30) 30 (25) 86 (27)
 High 40 (41) 36 (35) 54 (45) 130 (40)
Living situation:        
 Alone 34 (35) 33 (32) 35 (29) 102 (32)
 With partner 64 (65) 71 (68) 85 (71) 220 (68)
No of chronic diseases*:        
 0 59 (60) 64 (62) 63 (53) 186 (58)
 1 28 (29) 32 (31) 41 (34) 101 (31)
 2 8 (8) 4 (4) 12 (10) 24 (7)
 ≥3 3 (3) 4 (4) 4 (3) 11 (3)
Time since vestibular diagnosis†:        
 1-6 months 15 (15) 22 (21) 13 (11) 50 (16)
 6 months to 2 years 28 (29) 27 (26) 39 (33) 94 (29)
 2-10 years 31 (32) 44 (42) 48 (40) 123 (38)
 >10 years 23 (24) 11 (11) 18 (15) 52 (16)
Self reported vestibular diagnosis†:        
 No known diagnosis 67 (68) 69 (66) 77 (64) 213 (66)
 Benign paroxysmal positional vertigo 11 (11) 17 (16) 22 (18) 50 (16)
 Meniere’s disease 9 (9) 9 (9) 10 (8) 28 (9)
 Vestibular neuritis 6 (6) 4 (4) 7 (6) 17 (5)
 PPPD 0 (0) 1 (1) 0 (0) 1 (0)
 Other‡ 4 (4) 4 (4) 2 (2) 10 (3)
Disorders at baseline according to PHQ: 14 (14) 16 (15) 23 (19) 53 (17)
 Panic disorder 2 (2) 3 (3) 5 (4) 10 (3)
 Generalised anxiety disorder 12 (12) 15 (14) 19 (16) 46 (14
 Major depressive disorder 5 (5) 6 (6) 9 (8) 20 (6)
PPPD=persistent postural-perceptual dizziness; PHQ=patient health questionnaire.
*Chronic non-specific lung disease, cardiac disease, peripheral arterial disease, stroke, diabetes mellitus, arthritis, and cancer.
†Data on this variable was missing for three participants: stand alone VR (n=1), usual care (n=2).
‡Traumatic brain injury, cerebrovascular accident, Parkinson’s disease, bacterial meningitis, and vestibular organ surgical procedures.
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Adults aged ≥50 who visited their doctor for vestibular symptoms in past two years
Excluded by doctor
Severe comorbidity
No reason specified
Language problem
Non-vestibular cause
Head movement not possible
Other reasons
Participating in another study
491
449
228
132
36
36
1
3 month
follow-up
Stand alone vestibular
rehabilitation (VR)
Blended VR Usual care
6503
Invited to participate
5130
Assessed for eligibility by study physician
1373
Excluded
No response
Declined to participate
  No more vestibular symptoms
  No time or not interested
  No computer or internet
  Afraid of exercises
  Many comorbidities
  No reason specified
  In vestibular diagnostic analysis
3149
1336
4485
807
182
138
105
64
29
11
Excluded
No more vestibular symptoms
No vestibular symptoms
  exacerbated by head movements
No computer or internet
Language problem
Severe comorbidity
Vestibular symptoms for <1 month
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Fig 1 | Flow of participants through trial
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Secondary outcomes
Table 3 shows the comparison between the groups 
on dizziness related impairment, anxiety, depressive 
symptoms, and subjective improvement of vestibular 
symptoms. Participants in the stand alone and 
blended VR groups experienced less impairment from 
dizziness than participants in the usual care group 
at three and six months (adjusted mean difference 
on dizziness handicap inventory at 6 months −4.9 
points, 95% confidence interval −8.4 to −1.3, and −4.5 
points, −8.0 to −0.9). They also experienced fewer 
anxiety symptoms at three and six months (adjusted 
mean difference GAD-7 at 6 months −1.2 points, −2.0 
to −0.4, and −1.2 points, −2.0 to −0.4). No significant 
differences were found in severity of depressive 
symptoms between the VR groups and the usual care 
group at three and six months. At six months 46/87 
(53%) participants in the stand alone VR group, 48/93 
(52%) in the blended VR group, and 43/110 (39%) in 
the usual care group reported subjective improvement 
of vestibular symptoms compared with the start of 
the trial. Over the course of the trial, participants in 
the stand alone VR group and blended VR group were 
more likely to experience subjective improvement 
than participants in the usual care group (adjusted 
odds ratio stand alone VR versus usual care 2.2, 95% 
confidence interval 1.2 to 4.1; blended VR versus usual 
care 2.1, 1.2 to 3.8). No significant differences were 
found in self reported perceived barriers to adherence 
between participants in the stand alone VR group and 
blended VR group (supplementary appendix 4).
Serious adverse events
A total of 16 serious adverse events were reported 
during the trial—two participants died (one in the 
stand alone VR group and one in blended VR group), 
five were admitted to an intensive care unit (four in 
the stand alone VR group and one in the usual care 
group), and nine were admitted to hospital to a non-
intensive care unit (three in the stand alone VR group, 
two in the blended VR group, and four in the usual care 
group). None of the serious adverse events were judged 
to be related to vestibular symptoms or the treatment 
interventions.
Discussion
This three armed randomised controlled trial provides 
strong evidence for the effectiveness of online 
vestibular rehabilitation (VR) in general practice 
for adults with a chronic vestibular syndrome. After 
three and six months, participants in both the stand 
alone internet based VR group and the internet based 
VR group with physiotherapy support (blended VR) 
experienced significantly fewer vestibular symptoms 
than participants in the usual care group. They also 
experienced less dizziness related impairment, less 
anxiety, and more subjective improvement of vestibular 
symptoms. In the intention-to-treat-analysis the effects 
of stand alone VR and blended VR were comparable. In 
a per protocol analysis that only included participants 
who adhered fully to the intervention, the treatment 
effects of stand alone VR were notably better than in 
the intention-to-treat-analysis. No serious adverse 
events related to stand alone or blended VR occurred 
during the trial. In this trial, stand alone and blended 
VR showed significantly better effects than usual care 
at three and six months on both the primary outcome 
measure and three out of four secondary outcome 
measures, which points to the robustness of these 
findings.
Comparison with other studies
The positive effects of VR seen in this trial are in line 
with the results of previous VR randomised controlled 
trials in general practice.21 22 24 60 Internet based VR 
was previously investigated in only one randomised 
controlled trial in general practice.24 The stand alone 
intervention of Balance Retraining, the English version 
of our online intervention Vertigo Training, was 
associated with a significant reduction in vestibular 
symptoms and dizziness related impairment compared 
with usual care in British adults aged 50 and older.24 
The adjusted mean difference at six months in the 
vertigo symptom scale-short form (VSS-SF) score in 
Table 2 | Comparison of primary outcome between treatment groups
Primary outcome 
measure
Mean (SD) score Crude mean difference (95% CI)* Adjusted mean difference (95% CI)†
Stand  
alone VR Blended VR Usual care
Stand alone VR v  
usual care
Blended VR v  
usual care
Stand alone VR v  
usual care
Blended VR v  
usual care
VSS-SF  
(intention to treat)‡:
n=98 n=104 n=120 n=218 n=224 n=218 n=224
 Baseline 14.1 (8.9) 13.8 (8.3) 13.2 (8.6) - - - -
 3 months 8.1 (7.4) 8.6 (7.1) 11.5 (9.9) −4.2 (−5.9 to −2.5) −3.9 (−5.5 to −2.2) −4.3 (−5.9 to −2.6) −3.9 (−5.5 to −2.3)
 6 months 7.5 (7.8) 8.7 (6.9) 10.9 (9.3) −4.0 (−5.8 to −2.3) −3.5 (−5.1 to −1.8) −4.1 (−5.8 to −2.5) −3.5 (−5.1 to −1.9)
VSS-SF (per protocol)§: n=47 n=55 n=120 n=167 n=175 n=167 n=175
 Baseline 13.2 (6.2) 15.0 (8.6) 13.2 (8.6) - - - -
 3 months 6.0 (4.0) 10.0 (8.0) 11.5 (9.9) −6.0 (−8.1 to −4.0) −3.4 (−5.3 to −1.4) −6.0 (−8.0 to −3.9) −3.3 (−5.2 to −1.4)
 6 months 5.9 (5.0) 9.4 (7.4) 10.9 (9.3) −5.4 (−7.5 to −3.4) −3.6 (−5.6 to −1.7) −5.4 (−7.4 to −3.4) −3.5 (−5.5 to −1.6)
VR=vestibular rehabilitation; VSS-SF=vertigo symptom scale-short form, range 0-60, clinically relevant difference 3 points.
*Adjusted for baseline values and repeated measurements within participants.
†Adjusted for baseline values, repeated measurements within participants, age, sex, level of education, living situation, number of chronic diseases, time since vestibular diagnosis, and presence 
of a panic disorder, generalised anxiety disorder, or major depressive disorder at baseline.
‡All participants analysed according to allocation.
§Only participants in stand alone VR group who completed all six online sessions and participants in blended VR group who completed all six online sessions and both physiotherapist visits were 
analysed.
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that trial was 2.3 points (95% confidence interval 0.4 
to 4.1), favouring the online intervention. Our trial 
confirms the effectiveness of stand alone internet 
based VR in general practice. The larger difference we 
found in our stand alone VR group (4.1 points, 95% 
confidence interval 2.5 to 5.8) might be explained by 
better adherence to treatment (71% completed one 
session or more versus 61%) and a higher follow-
up rate (87% v 70%). Our trial assessed the value of 
guidance in internet based VR. Compared with usual 
care, blended VR was not different from stand alone 
VR in our trial in terms of effectiveness, self reported 
perceived barriers to adherence, and actual adherence 
to the online intervention. In treating patients with 
stress, anxiety, and depression, blended online 
interventions have shown benefits over stand alone 
internet based interventions.61-63 However, a review 
that examined blended internet based interventions 
in chronic somatic disorders showed inconsistent 
effects.64 The optimal quantity (number of face-to-face 
sessions) and quality of guidance (type of therapist) in 
internet based interventions are still unclear and might 
depend on the condition.65 The added value of support 
by a healthcare professional in chronic vestibular 
syndromes might be less than in anxiety or depressive 
disorders. In stand alone VR, participants received 
automated emails to promote adherence, and treatment 
was tailored to the participant’s vestibular symptoms, 
which might have been enough to encourage them 
to continue. Further research is needed to determine 
the added value of guidance in internet based VR. A 
qualitative interview study and a prediction study, 
announced in the published study protocol,33 are still 
in progress. Interviews with participants who received 
blended VR will provide insights into participants’ 
experiences, and a prediction rule might help to 
determine which type of patient will benefit most from 
therapeutic guidance.
Strengths and limitations of this study
Our study has several strengths. The trial was well 
powered, follow-up rates were high, and participants 
displayed good adherence to treatment interventions. 
The primary outcome measure we used, the VSS-SF, is 
an established patient reported outcome measure42 66 
that has been used in several VR trials.21 22 24 60 The 
pragmatic design of this trial with relatively broad 
inclusion criteria and no restrictions in usual care, 
allows general practitioners to directly apply the trial 
results in daily practice.
Our trial also has some limitations. Firstly, only 
a small percentage (<10%) of patients who were 
invited to participate enrolled in the trial, which 
might represent a selection bias. Of the 5130 invited 
participants, 3149 (61%) did not respond to our 
invitation. The low uptake may partly result from 
inviting patients who visited their doctor for vestibular 
symptoms in the past two years. Because 807 patients 
(60%) who declined to participate (see fig 1) reported 
that they no longer experienced vestibular symptoms, 
this might also be true for a large proportion of non-
responders. Participation was declined by 138 patients 
(10%) because they had no access to a computer or 
the internet. When we compared our trial sample 
with vestibular subgroup data from representative 
Dutch general practice studies on dizziness,8 54 our 
participants were more often men and the age group 85 
and older was underrepresented. Patients motivated to 
Table 3 | Comparison of secondary outcomes between treatment groups
Secondary outcome 
measures
Treatment group Crude mean difference (95% CI)* Adjusted mean difference (95% CI)†
Stand  
alone VR Blended VR Usual care
Stand alone VR v 
usual care
Blended VR v  
usual care
Stand alone VR v 
usual care
Blended VR v  
usual care
Mean (SD) score
DHI:              
 Baseline 34.8 (18.5) 36.0 (21.9) 35.8 (19.9) - - - -
 3 months 24.4 (20.8) 26.4 (20.6) 29.2 (21.1) −4.5 (−8.1 to −0.8) −3.9 (−7.5 to −0.3) −4.6 (−8.2 to −1.1) −3.9 (−7.4 to −0.4)
 6 months 21.5 (20.4) 25.4 (21.6) 27.6 (21.5) −4.7 (−8.4 to −1.1) −4.4 (−8.0 to −0.8) −4.9 (−8.4 to −1.3) −4.5 (−8.0 to −0.9)
GAD-7:              
 Baseline 3.7 (4.6) 4.0 (4.3) 4.5 (4.8) - - - -
 3 months 3.1 (3.8) 2.9 (3.4) 4.5 (5.0) −1.0 (−1.9 to −0.1) −1.3 (−2.2 to −0.5) −1.1 (−1.9 to −0.3) −1.4 (−2.2 to −0.6)
 6 months 2.6 (3.3) 2.7 (3.5) 4.2 (5.0) −1.1 (−1.9 to −0.2) −1.1 (−2.0 to −0.3) −1.2 (−2.0 to −0.4) −1.2 (−2.0 to −0.4)
PHQ-9:              
 Baseline 4.5 (4.7) 5.4 (4.5) 5.9 (5.4) - - - -
 3 months 4.2 (4.2) 4.3 (4.2) 5.3 (5.0) −0.3 (−1.3 to 0.6) −0.9 (−1.8 to 0.0) −0.5 (−1.4 to 0.4) −0.9 (−1.8 to 0.0)
 6 months 3.5 (4.3) 4.0 (3.7) 4.9 (5.1) −0.5 (−1.4 to 0.5) −0.8 (−1.7 to 0.2) −0.6 (−1.5 to 0.3) −0.8 (−1.7 to 0.1)
No (%) of patients reporting improvement
Subjective improvement:              
 3 months 49/91 (54) 54/97 (56) 39/107 (36) 2.1 (1.2 to 3.6)*‡§ 2.2 (1.2 to 3.8)*‡§ 2.2 (1.2 to 4.1)†‡¶ 2.1 (1.2 to 3.8)†‡¶
 6 months 46/87 (53) 48/93 (52) 43/110 (39)
VR=vestibular rehabilitation; DHI=dizziness handicap inventory, range 0-100; GAD-7= generalised anxiety disorder assessment (GAD)-7 subscale, a measure for severity of anxiety symptoms, 
range 0-21; PHQ-9=patient health questionnaire-9, a measure for severity of depressive symptoms, range 0-27; subjective improvement = dichotomous evaluation of vestibular symptoms 
compared to baseline measurement: improved or not improved (ie, worse or the same).
All analyses reported in table were performed on an intention-to-treat basis, with participants analysed according to allocation.
*Adjusted for baseline values and repeated measurements within participants.
†Adjusted for baseline values, repeated measurements within participants, age, sex, level of education, living situation, number of chronic disease, time since vestibular diagnosis, and presence 
of a panic disorder, generalised anxiety disorder, or major depressive disorder at baseline.
‡Comparison of overall effect over six months follow-up.
§Odds ratios (95% CI).
¶Adjusted odds ratios (95% CI).
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treat their vestibular symptoms with exercises might 
have been more likely to participate in the trial, which 
should be taken into account for implementation in 
daily general practice.
Secondly, we chose to include participants with 
a chronic vestibular syndrome and not a specified 
vestibular disorder. The effectiveness for VR was first 
shown in selected populations with various vestibular 
disorders, including benign paroxysmal positional 
vertigo, vestibular neuritis, Meniere’s disease, and 
unilateral and bilateral vestibulopathy.14 37 67 68 This 
formed the basis for later VR trials that applied a 
syndrome based approach to include patients who 
experienced symptoms related to these disorders.21 22 24 
These studies showed that VR can be effective when 
applied in patients with a syndrome diagnosis, 
which is important for general practice where a final 
vestibular diagnosis might not be available. In our 
trial, 213 participants (66%) reported that they had 
never received a diagnosis for a specific vestibular 
disorder. Previous studies in general practice have 
shown that general practitioners record a symptom 
diagnosis in one third of patients who present with 
vertigo or dizziness.8 54 As we endorse the importance 
of a specific vestibular diagnosis in general practice, 
all participating doctors received written instructions 
on how to diagnose and treat vestibular symptoms 
according to the Dutch guidelines,18 and participants 
received usual care without restrictions. Nevertheless, 
the absence of a specific vestibular diagnosis 
should not be a reason to withhold VR from patients 
when a chronic vestibular syndrome is present. We 
acknowledge that the inclusion of adults with chronic 
vestibular syndromes instead of specified vestibular 
disorder diagnoses entailed a higher risk of diagnostic 
uncertainty. However, we believe that VR is a low 
risk treatment, which according to the International 
Classification of Vestibular Disorders requires a lower 
level of diagnostic certainty.10 As more than 80% 
of patients with vestibular symptoms are treated by 
general practitioners without referral to secondary 
care,6-8 using a syndrome diagnosis over a disorder 
diagnosis might increase the uptake of VR because it is 
more applicable to daily general practice.
Thirdly, we compared stand alone VR and blended VR 
with usual care, the last being an inactive comparator 
group. In pragmatic trials it is common for usual care to 
be used as a control group to maximise applicability of 
the results of the trial in daily practice.69 Nevertheless, 
not providing any experimental treatment to partici-
pants in the usual care group could have affected 
the results. Unfortunately, it was not possible to 
blind participants to this exercise based treatment. 
Therefore, the difference in treatment effects between 
the intervention groups and usual care group might 
be partly explained by including an inactive control 
group. In people with Meniere’s disease and chronic 
vestibular symptoms, booklet based VR has been 
compared with both an inactive control group and 
an active control group where participants received a 
booklet on how to control their symptoms.37 Compared 
with the inactive control group in this trial, both 
vestibular symptoms (VSS-SF) and impairment due to 
dizziness (dizziness handicap inventory) decreased in 
the VR group, and only impairment due to dizziness 
decreased in the active control group. Also, previous 
trials have shown that improvement in subjective, 
patient reported outcomes after VR are accompanied 
by improvements in objective measures of balance 
function.14 22 70 Therefore it is unlikely that the findings 
of our study are explained solely by providing any form 
of experimental treatment.
Fourthly, the absence of serious adverse events 
related to online VR indicates this treatment is safe 
to use in general practice, but harms may have been 
underreported. Participants were asked about adverse 
reactions at the three and six month follow-up and 
were encouraged to report these directly to the trial 
team. Since contact with the trial team during the trial 
was minimal, participants might have forgotten to 
mention some harmful side effects. Because our results 
are consistent with previous VR studies, where serious 
adverse events were also absent,14 24 online VR can 
probably be considered a safe form of treatment.
Conclusions and implications for research and 
practice
Internet based VR is a safe and effective treatment for 
adults aged 50 and older with a chronic vestibular 
syndrome. Although further research is needed to 
determine if certain participants might benefit more from 
either stand alone or blended VR, this trial shows that 
both forms of internet based VR can reduce vestibular 
symptoms. By providing general practitioners with an 
easily accessible, low cost form of treatment, online 
VR has the potential to substantially improve care for 
a largely undertreated group of patients with a chronic 
vestibular syndrome in general practice.
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